Chemical Renal Denervation by Vincristine: The Role of the Flow Rate of Delivery
- 12 August 2014
- journal article
- laboratory investigation
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 37 (5) , 1336-1342
Abstract
Vincristine has been proven promising regarding its safety and efficacy for the renal artery denervation both in experimental models and in humans. The aim of the study was to compare in an experimental model the efficacy of constant versus random flow rate delivery of vincristine on renal sympathetic denervation.Keywords
This publication has 22 references indexed in Scilit:
- Sustained Sympathetic and Blood Pressure Reduction 1 Year After Renal Denervation in Patients With Resistant HypertensionHypertension, 2014
- A Controlled Trial of Renal Denervation for Resistant HypertensionNew England Journal of Medicine, 2014
- Chemical Renal Denervation in the RatCardioVascular and Interventional Radiology, 2013
- New double balloon delivery catheter for chemical denervation of the renal artery with vincristineInternational Journal of Cardiology, 2013
- Chemical denervation of the renal artery by vincristine in swine. A new catheter based techniqueInternational Journal of Cardiology, 2013
- Renal Artery Stenosis After Renal Sympathetic DenervationJACC, 2012
- Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited‐sampling, population modelling approachJournal of Paediatrics and Child Health, 2011
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trialThe Lancet, 2010
- Long‐Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue SarcomasSarcoma, 1998
- Reinnervation and renin release after unilateral renal denervation in the dog.Journal of Applied Physiology, 1972